Skip to main content

and
  1. Article

    Open Access

    Cyclovirobuxine D protects against diabetic cardiomyopathy by activating Nrf2-mediated antioxidant responses

    Diabetic cardiomyopathy (DCM) is the principal cause of death in people with diabetes. However, there is currently no effective strategy to prevent the development of DCM. Although cyclovirobuxine D (CVB-D) ha...

    Zhaohui Jiang, Lingyun Fu, Yini Xu, **aoxia Hu, Hong Yang in Scientific Reports (2020)